A French biotech firm is working on a drug for cancer care that uses bacteria from human feces, part of a pharma industry push to harness the microbiome and potentially revolutionize medicine.
Read the story on Bloomberg.com
👉 Drug From Bowel Bacteria Helps Blood Cancer Patients Facing Deadly Complication
https://www.bloomberg.com/news/articles/2025-01-08/drug-from-fecal-matter-helps-cancer-patients-facing-deadly-complication?utm_medium=social&utm_source=youtube&utm_campaign=originals&utm_content=article
1:45-2:47 — The microbiome and the potential of harnessing it
2:48-5:01 — Fecal microbiota transplant
5:02-7:08 — Experimental medication Maat013
7:09-7:37 — Survival rates when using fecal matter medicine
7:38-9:00 — How to turn fecal matter into medicine
9:01-9:21 — Big Pharma and microbiome therapies
9:22-12:30 — Can the microbiome revolutionize healthcare more broadly?
——–
Like this video? Subscribe: http://www.youtube.com/Bloomberg?sub_confirmation=1
Get unlimited access to Bloomberg.com for $1.99/month for the first 3 months: https://www.bloomberg.com/subscriptions?in_source=YoutubeOriginals
Bloomberg Originals offers bold takes for curious minds on today’s biggest topics. Hosted by experts covering stories you haven’t seen and viewpoints you haven’t heard, you’ll discover cinematic, data-led shows that investigate the intersection of business and culture. Exploring every angle of climate change, technology, finance, sports and beyond, Bloomberg Originals is business as you’ve never seen it.
Subscribe for business news, but not as you’ve known it: exclusive interviews, fascinating profiles, data-driven analysis, and the latest in tech innovation from around the world.
Visit our partner channel Bloomberg Quicktake for global news and insight in an instant.
source
